• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 80 of 100
House Oversight Hearing On Prescription Drug Price Increases
HealthMartin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike
By Sy MukherjeeMarch 17, 2016
HealthDoctors Who Get More Pharma Money Prescribe More Brand Name Drugs
By Sy MukherjeeMarch 17, 2016
BRITAIN-PHARMACEUTICAL-GSK
HealthGlaxo Starts Hunt for New CEO as Andrew Witty Flags Exit
By ReutersMarch 17, 2016
CA: Companies In California
TechMcKesson Plans Big Job Cuts To Trim Costs
By ReutersMarch 16, 2016
122486570
HealthThis Pharma CEO’s 2015 Pay Will Blow Your Mind
By Sy MukherjeeMarch 16, 2016
HealthSanofi Strikes $2.3 Billion Deal With DiCE Molecules
By ReutersMarch 16, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthThis One Stat Shows Why the Drug Price Issue Won’t Go Away
By Sy MukherjeeMarch 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthValeant Just Slashed Its Profit Guidance
By Reuters and Fortune EditorsMarch 15, 2016
Bernie Sanders Holds Super Tuesday Campaign Rally In Vermont
HealthBernie Sanders Just Proposed a Big Cash Prize to Make AIDS Drugs Cheaper
By Sy MukherjeeMarch 14, 2016
Drip
HealthWhy This Bristol-Myers Cancer Drug Is Crushing Its Rivals
By Sy MukherjeeMarch 14, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthThe White House Has Rejected a Controversial Way to Fight High Drug Prices
By Sy MukherjeeMarch 9, 2016
532377729
HealthThis Is How Medicare Wants to Lower Your Drug Costs
By Laura LorenzettiMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthBill Ackman Just Got Himself a Board Member on Valeant
By ReutersMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Shares of Valeant Are Jumping Today
By ReutersMarch 7, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthEurope Launches New Fast-Track Scheme for Drug Approval
By ReutersMarch 7, 2016
1...
  • 78
  • 79
  • 80
  • 81
  • 82
...100
Most Popular
Politics
After 93 years and a 25-hour filibuster, Washington finally has an income tax, and billionaires are already packing their bagsAn image of a popular article
By Catherina GioinoMarch 15, 2026
Commentary
Ray Dalio: I've studied 500 years of history and fear we're entering the most dangerous phase of the 'Big Cycle'An image of a popular article
By Ray DalioMarch 14, 2026
Workplace Culture
Gen Z is dating less. The result is one of the most unprepared workforcesAn image of a popular article
By Jake AngeloMarch 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.